Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ramm Pharma Corp C.RAMM

Healthcare
RAMM Pharma Corp., through its wholly-owned operating subsidiaries, is engaged in the pharmaceutical and medical product business, and is a leader in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. With RAMM’s large scale cultivation facility, the combined operations are expected to provide for complete vertical... see more

Recent & Breaking News (CSE:RAMM)

IIROC Trading Halt - RAMM

Canada NewsWire March 7, 2022

Ramm Pharma Announces Cease Trade Order

GlobeNewswire February 28, 2022

Ramm Pharma Announces Application for Management Cease Trade Order

GlobeNewswire February 22, 2022

RAMM Provides Update on European Operations

GlobeNewswire February 22, 2022

New CBD Regulatory Framework Published by France's Ministry of Health Opens New Commercial Opportunities for RAMM Pharma's European Operations

GlobeNewswire January 5, 2022

RAMM Pharma Corp. Welcomes Proposed Legalization of Recreational Cannabis in Germany

GlobeNewswire December 1, 2021

RAMM Pharma Announces Resignation of Director

GlobeNewswire September 15, 2021

RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

GlobeNewswire July 6, 2021

RAMM Pharma Completes Acquisition of Canapar Corp.

GlobeNewswire June 15, 2021

Canapar Corp. Receives Shareholder Approval for Business Combination With RAMM Pharma

GlobeNewswire June 14, 2021

IIROC Trade Resumption - RAMM

Canada NewsWire May 12, 2021

RAMM Pharma to Acquire 100% of Leading Vertically Integrated European Cannabis Company Canapar Corp.

GlobeNewswire May 12, 2021

IIROC Trading Halt - RAMM

Canada NewsWire May 12, 2021

RAMM Pharma Receives Federal Pharmaceutical Approval and Registration of NettaVet(TM) 10% CBD Formulation, a First for Veterinary Medicine

GlobeNewswire April 20, 2021

RAMM Pharma Commences Sales of NettaPet(TM) CBD Enriched Super Premium Quality Dog Food with Strong Pre-Order Demand

GlobeNewswire April 9, 2021

RAMM Pharma (CSE:RAMM) starts clinical trials of cannabinoid formulation in animals

Simon Druker  March 25, 2021

RAMM Pharma Initiates Clinical Trials of its Proprietary NettaVet(TM) Cannabinoid Formulation for Multiple Pathologies in Animals

GlobeNewswire March 25, 2021

RAMM Pharma Selected as COVID-19 Vaccine Fulfilment & Distribution Partner by the Uruguayan Ministry of Health

GlobeNewswire February 23, 2021

Canapar Welcomes RAMM Pharma as Strategic Shareholder; Closes $6,427,000 Financing

GlobeNewswire January 20, 2021

RAMM Pharma Makes Additional Investment in Canapar & Provides Overview of Strategic Acquisition to Enter European Cannabis Market

GlobeNewswire January 5, 2021